Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FF73X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,216
Award facts
- Contract value 100% obligated
- $10,215.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,215.75 to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pen injectors on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitive award uses firm fixed pricing and does not include a set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine medical supply transaction supporting federal healthcare operations.
This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to military healthcare systems and other federal agencies worldwide. The IDC facilitates flexible procurement of specialty medications and generic drugs across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent is used to treat conditions such as atopic dermatitis, asthma, and eosinophilic conditions, making this delivery consistent with the contract's broader scope of providing specialized pharmaceutical products to support military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FF73X?
SPE2DB25FF73X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FF73X worth?
The government has obligated $10,216 on SPE2DB25FF73X.
Is contract SPE2DB25FF73X an order under another contract?
Yes. SPE2DB25FF73X is a delivery order under SPE2DB20D1047, an indefinite delivery contract.
Was contract SPE2DB25FF73X competed?
The extent of competition for SPE2DB25FF73X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award